Projects per year
Search results
-
Active
-
Phase III_Parsaclisib and Ruxolitinib_Myelofibrosis_INCB 50465-313 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Combination of PI3K Inhibitor Parsaclisib and Ruxolitinib in Participants With Myelofibrosis
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
8/23/21 → …
Project: Clinical Trial
-
Sepsis Prediction with Deep Learning and Wearable Monitoring Patch'd
Pingali, S. R., Ganguly, S., Gotur, D. B., Jones, S. L., Masud, F. N. & Shah, S.
7/14/21 → …
Project: Clinical Trial
-
Phase 3_NavitoclaxRuxolitinib_Myelofibrosis_Abbvie M20-178 Transform-2
Shah, S., Ganguly, S., Pingali, S. R. & Rice, L.
6/7/21 → …
Project: Clinical Trial
-
Not started
-
Phase II_PevonedistatVenetoclaxAzacitidine_AML_Pevonedistat-2002Takeda A Randomized, Open-label, Controlled, Phase 2 Study of Pevonedistat, Venetoclax, and Azacitidine Versus Venetoclax Plus Azacitidine in Adults With Newly Diagnosed Acute Myeloid Leukemia Who Are Unfit for Intensive Chemotherapy
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
Project: Clinical Trial
-
Circulating tumor DNA 5-hydroxymethylcytosine as a novel biomarker for cancers.
Li, Z., Bernicker, E. H., Chang, J. C., Darcourt, J., Pingali, S. R., Sahay, S., Shah, S., Singh, M., Zhang, J., Zhou, S. & Zu, Y.
Project: Clinical Trial
-
A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
Project: Clinical Trial
-
Phase 3 Randomized, Controlled Study of Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia With Safety Run-in
Shah, S., Ganguly, S., Petkova, J., Pingali, S. R. & Rice, L.
Project: Clinical Trial